Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer

YUSUKE TAKASHIMA, SHUHEI KOMATSU, MASATAKA KASUGA, TAKUMA OHASHI, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO and EIGO OTSUJI
Anticancer Research January 2022, 42 (1) 237-243; DOI: https://doi.org/10.21873/anticanres.15478
YUSUKE TAKASHIMA
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUHEI KOMATSU
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: skomatsu{at}koto.kpu-m.ac.jp
MASATAKA KASUGA
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKUMA OHASHI
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROTAKA KONISHI
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATSUSHI SHIOZAKI
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI KUBOTA
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HITOSHI FUJIWARA
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUMA OKAMOTO
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EIGO OTSUJI
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: This retrospective study investigated the clinical significance of vertical location in gastric cancer (GC) and the optimal treatment strategy according to the vertical location. Patients and Methods: Between 1997 and 2018, 1,304 consecutive patients with GC who underwent curative surgical resection with lymphadenectomy were analyzed retrospectively. Results: Patients with GC in the anterior wall (AW) had a significantly better prognosis compared to those in other sites of the lower third stomach (p=0.040). Multivariate analysis showed that tumor location in the AW was an independent prognostic factor and was associated with a lower incidence of lymph node metastasis (LNM) (p=0.023). The frequency of LNM in the area of D2 was lower in patients with AW GC than those with GC in other locations. Conclusion: Patients with AW GC had a favorable prognosis, with a lower incidence of LNM in lower-third GC.

Key Words:
  • Vertical location
  • anterior wall
  • lymph node metastasis
  • gastric cancer

Gastric cancer (GC) is the fifth most common cancer and the third leading cause of death worldwide (1). The concept of cancer stage was established according to the Tumor-Node-Metastasis (TNM) classification by the Union for International Cancer Control (UICC) (2) and American Joint Committee on Cancer (AJCC) (3) to evaluate prognosis and determine treatment strategy (4, 5). As the staging system shows, lymph node metastasis (LNM) is one of the strongest prognostic factors (6, 7), and the optimal range of lymph node dissection has been reported according to preoperative diagnosis of cancer progression (8, 9).

An adequate extent of lymph node dissection is necessary to prevent the lymphatic progression of GC. Therefore, based on the results of research on lymphatic flow in GC, Japanese guidelines recommend the optimal lymphatic dissection area for radical GC surgery according to the horizontal location of GC (4). However, although there are several reports about the correlation between vertical tumor location and GC prognosis, the clinical effects of vertical tumor location on LNM have not been fully elucidated, except for the recent definition of combined splenectomy, which has not been recommended to avoid upper-third advanced GC that does not invade the greater curvature (10, 11).

In the present study, we hypothesized that tumor location in the vertical section of GC would be associated with prognosis and LNM based on a previous report suggesting that the vertical distance of the tumor from the main extramural lymphatic flow affects lymphatic metastasis and prognosis in esophageal cancer (12). To verify these hypotheses, we evaluated the prognosis according to the vertical location and incidence of LNM. Our results suggested that GC location on the anterior wall might serve as a favorable prognostic factor and result in lower LNM frequency in GC.

Patients and Methods

Patients. This study was approved by the Kyoto Prefectural University of Medicine and was performed under the ethical standards described in an appropriate version of the Declaration of Helsinki. A total of 1,721 consecutive patients underwent curative gastrectomy with lymphadenectomy for GC at our institute between January 1997 and December 2018. Of these 1,721 patients, 417 were excluded from the study because of multiple carcinomas (n=204), insufficient clinical data (n=60), remnant GC (n=49), circumferential involvement (n=66), or other reasons (n=38). Therefore, we investigated 1,304 consecutive patients (Figure 1A). The median follow-up period was 5.3 years (interquartile range=3.0-7.3 years). The resected specimens were examined by pathologists and evaluated based on the Japanese Classification of GC. All dissected lymph nodes were fixed in buffered formalin, embedded in paraffin, and subjected to pathological examination. Pathologists in our institution examined the lymph nodes by sectioning slices in the plane of the largest node dimension to confirm the presence of metastasis. The clinicopathological findings of these patients were retrospectively obtained based on their medical records.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Enrolled patients and definition of tumor laterality. (A) A total of 1,721 patients underwent curative gastrectomy with lymphadenectomy between January 1997 and December 2018. Of these, 417 patients were excluded from the study. Thus, data from 1,304 consecutive patients were obtained from their hospital records and retrospectively analyzed. (B) Of the 1,304 patients, 250 had gastric cancer in the anterior wall (19.2%), 299 in the posterior wall (22.9%), 553 in the lesser curvature (42.4%), and 202 in the greater curvature (15.5%).

Definitions of vertical and horizontal locations and regional lymph nodes. The stomach was divided into three portions; namely, the upper third part (U), middle third (M), and lower third (L), while the cross-sectional circumference of the stomach was divided into four parts – the lesser curvature (LC), greater curvature, anterior wall (AW), and posterior wall (PW) – according to the Japanese Classification of GC (13). The tumor location was determined according to its main position. Of the 1,304 patients, 250 had GC in the AW (19.2%), 299 in the PW (22.9%), 553 in the LC (42.4%), and 202 patients in the greater curvature (15.5%) (Figure 1B). The differences in surgical outcomes and clinicopathological factors were compared between patients with GC in the AW and the other vertical locations. The differences in the locations of LNM were estimated according to a previous Japanese classification system (14), in which the regional lymph nodes were classified depending on the location of the primary tumor.

Statistical analysis. Statistical analyses were conducted using JMP version 16 (SAS Institute Inc., Cary, NC, USA). Mann–Whitney U-tests for unpaired data of continuous variables were used to compare clinicopathological variables. For survival analysis, Kaplan–Meier survival curves were constructed for groups based on univariate predictors, and differences between the groups were tested using generalized Wilcoxon tests. A Cox proportional hazards model was used for further evaluation of the multivariate survival analysis. Statistical significance was set at p<0.05.

Results

Anterior wall location showed favorable prognosis in lower-third GC. Figure 2 shows the 5-year overall survival (5yr-OS) curves for each of the three stomach sites. For lower-third gastric cancer, patients with GC in the AW had a significantly better prognosis compared to those in the other sites (p=0.040), and the 5yr-OS was 90.2% for AW, 85.3% for PW, 80.0% for GC, and 77.0% for LC, respectively. Regarding the upper and middle third gastric locations, there was no difference in the 5-yr OS rate between the AW and the other locations. Therefore, we focused on lower-third gastric cancer in our further analyses.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Comparisons of 5-year overall survival (OS) rates according to tumor laterality. (A) Comparisons of 5-year OS rates in upper-third gastric cancer. (B) Comparisons of 5-year OS rates in middle-third gastric cancer. (C) Comparisons of 5-year OS rates in lower-third gastric cancer. (D) Comparisons of 5-year OS rates in lower-third gastric cancer located in the anterior wall and other locations.

Univariate and multivariate analysis using Cox’s proportional hazard model. Univariate and multivariate analyses using Cox’s proportional hazard model were performed to elucidate the prognostic factors for OS in patients with lower-third gastric cancer. As shown in Table I, the clinical variables included sex, age, pT stage, pN stage, tumor size, histological type, venous invasion, lymphatic invasion, and cross-section. The results of multivariate analysis showed that AW [p=0.040, hazard ratio (HR)=2.30, 95% confidence interval (CI)=1.06-6.04] was an independent prognostic factor along with pT stage, pN stage, and tumor size.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Results of univariate and multivariate analysis using Cox’s proportional hazard model.

Comparisons of clinicopathological factors between patients with AW GC and GC in other locations in the lower third of the stomach. Table II shows the results of the comparisons of clinicopathological factors between AW and the other GC locations in the lower third of the stomach. GC in the AW was associated with lower incidences of lymphatic invasion (p=0.043) and LNM (p=0.023) compared to the other sites. No other significant differences in other clinicopathological factors were observed between the two groups. A logistic regression analysis of clinicopathological factors found that not-AW site was associated with LNM [p=0.016; odds ratio (OR)=2.63, 95%CI=1.19-6.41] as well as advanced pT, undifferentiated histological, lymphatic invasion, and venous invasion (Table III).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Comparisons of clinicopathological factors between patients with gastric cancer located in the anterior wall and other locations in the lower third of the stomach.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Risk factors for lymph node metastasis in lower-third gastric cancer.

Comparisons of AW GC to GC in other locations on LNM. We next compared the region of LNM based on the Japanese Classification of Gastric Carcinoma, 3rd edition. In early GC, there were no significant differences in LNMs between vertical tumor locations in the areas of lymph node stations D1 and D2. In contrast, patients with advanced AW GC tended to have a lower incidence of LNM in the area of D1 (p=0.098) and a significantly lower incidence of LNM in the area of D2 compared to the incidences in other locations (p=0.030) (Figure 3).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Comparisons of the incidence of lymph node metastasis (LNM) between patients with gastric cancer (GC) on the anterior wall (AW) and other locations. In advanced GC, there was a lower incidence of LNM in the area of D2 resection in the AW compared to those in the other locations. However, in early GC, there was no difference in LNM between locations in the areas of D1 and D2 resection. The LNM area was based on the Japanese Classification of Gastric Carcinoma, 3rd edition. GC: Gastric cancer; LNM: lymph node metastasis; AW: anterior wall.

Discussion

Mine et al. demonstrated that vertical tumor location, also known as tumor laterality, affects prognosis and systemic lymphatic metastases in esophageal cancer. Patients with esophageal tumors on the right and dorsal sides, which were near the thoracic duct, have poorer prognoses due to the high frequency of hematogenous metastasis (12). However, few reports have assessed the influence of tumor laterality on the prognosis and LNM of GC (15). The results of this study demonstrated that AW position was an independent prognostic factor in third-lower GC (p=0.040, HR=2.30, 95%CI=1.06-6.04). Moreover, patients with AW GC tended to have fewer LNMs, especially in the D2 region. These results indicated that cancer laterality could be an important indicator of prognosis and LNM in lower-third GC, strongly suggesting that the distance from the main lymphatic flow may be closely related to LNM.

The most striking finding in the present study was that the patients with AW GC had significantly fewer LNMs in the area of station D2 lymph nodes in the lower third of the stomach. From the viewpoint of the distance from the tumor to the main lymphatic flow, presumably, GC located on the greater curvature wall is more likely to metastasize to lymph node station No.6 (16), which has lymphatic flow to stations No.14v and No.16, making lymphadenectomy difficult (17-19). Jung et al. reported a worse prognosis in patients with GC on the greater curvature than those in patients with GC with other locations (15). Meanwhile, GC on the lesser curvature wall might metastasize to lymph node stations No.3 and 5, which have lymphatic flow to station Nos.7, 8a, and 12a. GC of the PW also metastasizes to station No.11p due to lymphatic flow of the posterior artery. Regarding remnant GC, tumor location in the greater curvature was reported to be an independent risk factor for LMN, especially lymph node Nos.4sb and 10 (20). The lymphatic flows of the greater curvature and splenic hilum are preserved as the main lymphatic flow after the initial gastrectomy (21). Thus, these previous reports strongly suggest that the vertical tumor location is also a pivotal indicator of prognosis and LNM as well as histological type (22, 23), lymphatic vessel invasion (24, 25), and venous invasion (26, 27) in GC.

The gastric lymphatic compartments are divided according to the five directions along the main feeding arteries, namely, the left gastric, right gastric, left gastroepiploic, right gastroepiploic, and posterior gastric arteries, based on detailed anatomical studies of the lymphatic drainage of GC (16, 28). The AW is located a comparatively longer distance from these main feeding arteries and major lymphatic flows, which may be related to the different frequencies of LNM. These results may lead to the potential for minimized gastrectomy for AW GC in elderly or high-risk patients for whom extended invasive gastrectomy might be a risk factor for postoperative complications (29, 30) and also to stratify GC patients to undergo functional preserving gastrectomy leading to favorable postoperative outcomes (31).

This study had some limitations, as the results were obtained from a retrospective evaluation of a small number of patients at a single institute. Moreover, the findings require validation in a larger prospective multicenter study using a standardized surgical approach. Nevertheless, our findings suggest the impact of tumor laterality on the prognosis of GC patients due to lymphatic flow entering the systemic circulation. Moreover, patients with GC in locations other than the AW might benefit from formal lymphadenectomy due to the higher incidence of lymph node involvement.

Footnotes

  • Authors’ Contributions

    YT, SK designed and SK, EO reviewed the research; YT, SK drafted the manuscript; SK, MK, TO, HK, AS, TK, HF, KO and EO provided clinical data and performed analyses. All Authors read and approved the final manuscript.

  • ↵* These Authors contributed equally to this work.

  • Conflicts of Interest

    The Authors have no conflicts of interest to disclose in relation to this study.

  • Received October 11, 2021.
  • Revision received November 2, 2021.
  • Accepted November 3, 2021.
  • Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

References

  1. ↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA and
    6. Jemal A
    : Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6): 394-424, 2018. PMID: 30207593. DOI: 10.3322/caac.21492
    OpenUrlCrossRefPubMed
  2. ↵
    1. Brierley JD,
    2. Gospodarowicz MK and
    3. Wittekind C
    : TNM classification of malignant tumors, 8th edition, UICC, 2017.
  3. ↵
    1. Amin MB,
    2. Edge S,
    3. Greene F,
    4. Byrd DR,
    5. Brookland RK,
    6. Washington MK,
    7. Gershenwald JE,
    8. Compton CC,
    9. Hess KR,
    10. Sullivan DC,
    11. Jessup JM,
    12. Brierley JD,
    13. Gaspar LE,
    14. Schilsky RL,
    15. Balch CM,
    16. Winchester DP,
    17. Asare EA,
    18. Madera M,
    19. Gress DM and
    20. Meyer LR
    : American joint committee on cancer (AJCC) cancer staging manual, 8th edition. Springer International Publishing, 2017.
  4. ↵
    1. Japanese Gastric Cancer Association
    : Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24(1): 1-21, 2021. PMID: 32060757. DOI: 10.1007/s10120-020-01042-y
    OpenUrlCrossRefPubMed
  5. ↵
    1. Smyth EC,
    2. Verheij M,
    3. Allum W,
    4. Cunningham D,
    5. Cervantes A,
    6. Arnold D and ESMO Guidelines Committee
    : Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5): v38-v49, 2016. PMID: 27664260. DOI: 10.1093/annonc/mdw350
    OpenUrlCrossRefPubMed
  6. ↵
    1. Okajima W,
    2. Komatsu S,
    3. Ichikawa D,
    4. Kosuga T,
    5. Kubota T,
    6. Okamoto K,
    7. Konishi H,
    8. Shiozaki A,
    9. Fujiwara H and
    10. Otsuji E
    : Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol 31(9): 1566-1571, 2016. PMID: 26840392. DOI: 10.1111/jgh.13306
    OpenUrlCrossRefPubMed
  7. ↵
    1. Komatsu S,
    2. Ichikawa D,
    3. Miyamae M,
    4. Kosuga T,
    5. Okamoto K,
    6. Arita T,
    7. Konishi H,
    8. Morimura R,
    9. Murayama Y,
    10. Shiozaki A,
    11. Kuriu Y,
    12. Ikoma H,
    13. Nakanishi M,
    14. Fujiwara H and
    15. Otsuji E
    : Positive lymph node ratio as an indicator of prognosis and local tumor clearance in N3 gastric cancer. J Gastrointest Surg 20(9): 1565-1571, 2016. PMID: 27353383. DOI: 10.1007/s11605-016-3197-9
    OpenUrlCrossRefPubMed
  8. ↵
    1. Sasako M,
    2. McCulloch P,
    3. Kinoshita T and
    4. Maruyama K
    : New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82(3): 346-351, 1995. PMID: 7796005. DOI: 10.1002/bjs.1800820321
    OpenUrlCrossRefPubMed
  9. ↵
    1. Mogal H,
    2. Fields R,
    3. Maithel SK and
    4. Votanopoulos K
    : In patients with localized and resectable gastric cancer, what is the optimal extent of lymph node dissection-D1 versus D2 versus D3? Ann Surg Oncol 26(9): 2912-2932, 2019. PMID: 31076930. DOI: 10.1245/s10434-019-07417-5
    OpenUrlCrossRefPubMed
  10. ↵
    1. Sano T,
    2. Coit DG,
    3. Kim HH,
    4. Roviello F,
    5. Kassab P,
    6. Wittekind C,
    7. Yamamoto Y and
    8. Ohashi Y
    : Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 20(2): 217-225, 2017. PMID: 26897166. DOI: 10.1007/s10120-016-0601-9
    OpenUrlCrossRefPubMed
  11. ↵
    1. Komatsu S and
    2. Otsuji E
    : Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan. Ann Gastroenterol Surg 3(6): 581-591, 2019. PMID: 31788646. DOI: 10.1002/ags3.12284
    OpenUrlCrossRefPubMed
  12. ↵
    1. Mine S,
    2. Yamada K,
    3. Grabsch H,
    4. Sano T,
    5. Ishiyama A,
    6. Hirasawa T,
    7. Yamamoto N,
    8. Hiki N and
    9. Yamaguchi T
    : The prognostic significance of tumor laterality in patients with esophageal squamous cell carcinoma. J Surg Oncol 105(1): 66-70, 2012. PMID: 21842522. DOI: 10.1002/jso.22069
    OpenUrlCrossRefPubMed
  13. ↵
    1. Japanese Gastric Cancer Association
    : Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2): 101-112, 2011. PMID: 21573743. DOI: 10.1007/s10120-011-0041-5
    OpenUrlCrossRefPubMed
  14. ↵
    1. Japanese Gastric Cancer Association
    : Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1(1): 10-24, 1998. PMID: 11957040. DOI: 10.1007/s101209800016
    OpenUrlCrossRefPubMed
  15. ↵
    1. Jung YJ,
    2. Seo HS,
    3. Kim JH,
    4. Park CH and
    5. Lee HH
    : Cross-sectional location of gastric cancer affects the long-term survival of patients as tumor invasion deepens. Ann Surg Oncol 24(13): 3947-3953, 2017. PMID: 28980179. DOI: 10.1245/s10434-017-6101-2
    OpenUrlCrossRefPubMed
  16. ↵
    1. Shida A,
    2. Mitsumori N,
    3. Fujioka S,
    4. Takano Y,
    5. Fujisaki M,
    6. Hashizume R,
    7. Takahashi N,
    8. Ishibashi Y and
    9. Yanaga K
    : Sentinel node navigation surgery for early gastric cancer: Analysis of factors which affect direction of lymphatic drainage. World J Surg 42(3): 766-772, 2018. PMID: 28920152. DOI: 10.1007/s00268-017-4226-x
    OpenUrlCrossRefPubMed
  17. ↵
    1. Han WH,
    2. Joo J,
    3. Eom BW,
    4. Ryu KW,
    5. Kim YW,
    6. Kook MC and
    7. Yoon HM
    : Factors associated with metastasis in superior mesenteric vein lymph node in subtotal gastrectomy for gastric cancer: Retrospective case control study. Chin J Cancer Res 32(1): 43-50, 2020. PMID: 32194304. DOI: 10.21147/j.issn.1000-9604.2020.01.06
    OpenUrlCrossRefPubMed
    1. Yu P,
    2. Du Y,
    3. Xu Z,
    4. Huang L and
    5. Cheng X
    : Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study. World J Surg Oncol 17(1): 28, 2019. PMID: 30728027. DOI: 10.1186/s12957-019-1572-1
    OpenUrlCrossRefPubMed
  18. ↵
    1. Zheng C,
    2. Gao ZM,
    3. Sun AQ,
    4. Huang HB,
    5. Wang ZN,
    6. Li K and
    7. Gao S
    : Prognostic significance of 14v-lymph node dissection to D2 dissection for lower-third gastric cancer. World J Clin Cases 7(18): 2712-2721, 2019. PMID: 31616687. DOI: 10.12998/wjcc.v7.i18.2712
    OpenUrlCrossRefPubMed
  19. ↵
    1. Takahashi K,
    2. Yoshikawa T,
    3. Morita S,
    4. Kinoshita T,
    5. Yura M,
    6. Otsuki S,
    7. Tokunaga M,
    8. Yamagata Y,
    9. Kaito A and
    10. Katai H
    : Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer. Gastric Cancer 23(1): 195-201, 2020. PMID: 31302790. DOI: 10.1007/s10120-019-00989-x
    OpenUrlCrossRefPubMed
  20. ↵
    1. Komatsu S,
    2. Ichikawa D,
    3. Okamoto K,
    4. Ikoma D,
    5. Tsujiura M,
    6. Shiozaki A,
    7. Fujiwara H,
    8. Murayama Y,
    9. Kuriu Y,
    10. Ikoma H,
    11. Nakanishi M,
    12. Ochiai T,
    13. Kokuba Y and
    14. Otsuji E
    : Differences of the lymphatic distribution and surgical outcomes between remnant gastric cancers and primary proximal gastric cancers. J Gastrointest Surg 16(3): 503-508, 2012. PMID: 22215245. DOI: 10.1007/s11605-011-1804-3
    OpenUrlCrossRefPubMed
  21. ↵
    1. Popiela T,
    2. Kulig J,
    3. Kolodziejczyk P,
    4. Sierzega M and Polish Gastric Cancer Study Group
    : Long-term results of surgery for early gastric cancer. Br J Surg 89(8): 1035-1042, 2002. PMID: 12153632. DOI: 10.1046/j.1365-2168.2002.02156.x
    OpenUrlCrossRefPubMed
  22. ↵
    1. Miyamae M,
    2. Komatsu S,
    3. Ichikawa D,
    4. Kosuga T,
    5. Kubota T,
    6. Okamoto K,
    7. Konishi H,
    8. Shiozaki A,
    9. Fujiwara H,
    10. Kishimoto M and
    11. Otsuji E
    : Histological mixed-type as an independent risk factor for nodal metastasis in submucosal gastric cancer. Tumour Biol 37(1): 709-714, 2016. PMID: 26242270. DOI: 10.1007/s13277-015-3864-6
    OpenUrlCrossRefPubMed
  23. ↵
    1. Hyung WJ,
    2. Lee JH,
    3. Choi SH,
    4. Min JS and
    5. Noh SH
    : Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9(6): 562-567, 2002. PMID: 12095972. DOI: 10.1007/BF02573892
    OpenUrlCrossRefPubMed
  24. ↵
    1. Zhang CD,
    2. Ning FL,
    3. Zeng XT and
    4. Dai DQ
    : Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis. Int J Surg 53: 214-220, 2018. PMID: 29609047. DOI: 10.1016/j.ijsu.2018.03.073
    OpenUrlCrossRefPubMed
  25. ↵
    1. Bayar S,
    2. Saxena R,
    3. Emir B and
    4. Salem RR
    : Venous invasion may predict lymph node metastasis in early rectal cancer. Eur J Surg Oncol 28(4): 413-417, 2002. PMID: 12099652. DOI: 10.1053/ejso.2002.1254
    OpenUrlCrossRefPubMed
  26. ↵
    1. Kang HJ,
    2. Chung H,
    3. Kim SG,
    4. Kim J,
    5. Kim JL,
    6. Lee E and
    7. Jung HC
    : Synergistic effect of lymphatic invasion and venous invasion on the risk of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. J Gastrointest Surg 24(7): 1499-1509, 2020. PMID: 31313145. DOI: 10.1007/s11605-019-04302-0
    OpenUrlCrossRefPubMed
  27. ↵
    1. Miwa K,
    2. Kinami S,
    3. Taniguchi K,
    4. Fushida S,
    5. Fujimura T and
    6. Nonomura A
    : Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 90(2): 178-182, 2003. PMID: 12555293. DOI: 10.1002/bjs.4031
    OpenUrlCrossRefPubMed
  28. ↵
    1. Watanabe M,
    2. Miyata H,
    3. Gotoh M,
    4. Baba H,
    5. Kimura W,
    6. Tomita N,
    7. Nakagoe T,
    8. Shimada M,
    9. Kitagawa Y,
    10. Sugihara K and
    11. Mori M
    : Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg 260(6): 1034-1039, 2014. PMID: 25072429. DOI: 10.1097/SLA.0000000000000781
    OpenUrlCrossRefPubMed
  29. ↵
    1. Kurita N,
    2. Miyata H,
    3. Gotoh M,
    4. Shimada M,
    5. Imura S,
    6. Kimura W,
    7. Tomita N,
    8. Baba H,
    9. Kitagawa Y,
    10. Sugihara K and
    11. Mori M
    : Risk model for distal gastrectomy when treating gastric cancer on the basis of data from 33,917 Japanese patients collected using a nationwide web-based data entry system. Ann Surg 262(2): 295-303, 2015. PMID: 25719804. DOI: 10.1097/SLA.0000000000001127
    OpenUrlCrossRefPubMed
  30. ↵
    1. Kulig P,
    2. Nowakowski P,
    3. Sierzęga M,
    4. Pach R,
    5. Majewska O,
    6. Markiewicz A,
    7. Kołodziejczyk P,
    8. Kulig J and
    9. Richter P
    : Analysis of prognostic factors affecting short-term and long-term outcomes of gastric cancer resection. Anticancer Res 41(7): 3523-3534, 2021. PMID: 34230148. DOI: 10.21873/anticanres.15140
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 42, Issue 1
January 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer
YUSUKE TAKASHIMA, SHUHEI KOMATSU, MASATAKA KASUGA, TAKUMA OHASHI, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO, EIGO OTSUJI
Anticancer Research Jan 2022, 42 (1) 237-243; DOI: 10.21873/anticanres.15478

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer
YUSUKE TAKASHIMA, SHUHEI KOMATSU, MASATAKA KASUGA, TAKUMA OHASHI, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO, EIGO OTSUJI
Anticancer Research Jan 2022, 42 (1) 237-243; DOI: 10.21873/anticanres.15478
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Tolerance and Outcomes of Partial Breast Radiation in a Community-based Setting
  • Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status
  • Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study
Show more Clinical Studies

Keywords

  • Vertical location
  • anterior wall
  • lymph node metastasis
  • Gastric cancer
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire